Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096128
Filing Date
2024-08-13
Accepted
2024-08-13 16:00:22
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20240630.htm   iXBRL 10-Q 1738411
2 EX-31.1 isco-ex31_1.htm EX-31.1 12192
3 EX-31.2 isco-ex31_2.htm EX-31.2 12164
4 EX-32.1 isco-ex32_1.htm EX-32.1 7357
5 EX-32.2 isco-ex32_2.htm EX-32.2 7926
  Complete submission text file 0000950170-24-096128.txt   8921687

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20240630.xsd EX-101.SCH 1067706
73 EXTRACTED XBRL INSTANCE DOCUMENT isco-20240630_htm.xml XML 2007260
Mailing Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131
Business Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 241201182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)